The Healing NET Foundation mission is to optimize the care of those with neuroendocrine cancer through the education of and collaboration among physicians, health care providers, patients, and caregivers. 

The Healing NET Foundation began with a connection between a neuroendocrine cancer patient and the expert physician who treated her. Cindy Lovelace and Dr. Eric Liu are Co-Founders of The Healing NET Foundation, a nonprofit, 501(c)(3) organization.

They recently reflected on their work to advance NET care. Click here for the interview on curetoday.com.

They are joined in this work by a dedicated board of directors. Click here for bios of our board members.

Neuroendocrine tumors (NETs) are an unusual set of malignancies that affect patients of all ages, races, and backgrounds.  The tumors are difficult to diagnose and can cause many unusual symptoms which often lead to improper diagnosis or significantly delayed diagnosis. Overall physician knowledge is typically limited, inaccurate, or outdated. There is a need for education and communication to help medical professionals more quickly diagnose and more effectively treat NETs.  

Neuroendocrine cancer often requires the skills of many specialty medical fields, including surgery, oncology, endocrinology, gastroenterology, radiology, nuclear medicine, pathology, general medicine, pulmonology, cardiology, and possibly pediatrics.

NET patients rely on nurse navigators, nutritionists, social workers, palliative care, and others. Patients may be frustrated by a lack of answers or confusing recommendations from multiple physicians.  

Healing NET’s focus is advocating for a new standard of care NET patients deserve.  

Healing NET Co-FOUNDERS ERIC LIU and cindy lovelace

Healing NET Co-FOUNDERS ERIC LIU and cindy lovelace

The Healing NET Foundation was founded by individuals with a common desire to bring neuroendocrine cancer from the obscurity of the “cancer that Steve Jobs had” to a level of understanding that neuroendocrine tumors are often very treatable forms of cancer; many patients can live long lives of high quality.   We understand it first-hand, as physicians or as patients.